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Mammalian genomes contain long domainswith distinct average compositions of A/T versusG/C base pairs.
In a screen for proteins that might interpret base composition by binding to AT-rich motifs, we identified the
stem cell factor SALL4, which contains multiple zinc fingers. Mutation of the domain responsible for AT bind-
ing drastically reduced SALL4 genome occupancy and prematurely upregulated genes in proportion to their
AT content. Inactivation of this single AT-binding zinc-finger cluster mimicked defects seen in Sall4 null cells,
including precocious differentiation of embryonic stem cells (ESCs) and embryonic lethality in mice. In
contrast, deletion of two other zinc-finger clusters was phenotypically neutral. Our data indicate that loss
of pluripotency is triggered by downregulation of SALL4, leading to de-repression of a set of AT-rich genes
that promotes neuronal differentiation. We conclude that base composition is not merely a passive byprod-
uct of genome evolution and constitutes a signal that aids control of cell fate.
INTRODUCTION
A/T and G/C base pairs are nonrandomly distributed within
mammalian genomes, forming large and relatively homoge-
neous AT-rich or GC-rich regions that usually encompass
several genes together with their intergenic sequences. Base
compositional domains are often evolutionarily conserved (Ber-
nardi et al., 1985; Holmquist, 1989; Bickmore and Sumner,
1989; Costantini et al., 2009) and coincide with other genomic
features (Bickmore and van Steensel, 2013), including early/
late-replicating regions (Hiratani et al., 2009; Holmquist et al.,
1982), lamina-associated domains (Meuleman et al., 2013),
and topologically associating domains (Jabbari and Bernardi,
2017). Despite these interesting correlations, it is unclear
whether conserved AT-rich and GC-rich domains are passive
byproducts of evolution or DNA base composition can play an
active biological role (Eyre-Walker and Hurst, 2001; Duret
et al., 2006; Arhondakis et al., 2011). Exemplifying this second
hypothesis, CpG islands represent conserved GC-rich domains
(Bird, 1986) that are specifically bound by proteins recognizing
unmethylated ‘‘CG’’ dinucleotides (Lee et al., 2001; Voo et al.,
2000) to modulate chromatin structure and regulate gene
expression (Thomson et al., 2010; Blackledge et al., 2010; Far-
cas et al., 2012; Wu et al., 2013; He et al., 2013).
Here, we tested the hypothesis that AT-rich DNA can be inter-
preted by specific proteins that recognize short AT-rich motifs
whose frequency tracks fluctuations in base composition across
the genome (Quante and Bird, 2016). To identify novel AT-bind-
ing proteins, we utilized a DNA pull-down mass spectrometry
screen in mouse embryonic stem cells (ESCs), which are plurip-
otent and can be differentiated in culture. As a top hit, we iden-
tified SALL4, which is a multi-zinc-finger protein that restrains
differentiation of ESCs (Yuri et al., 2009; Miller et al., 2016) and
participates in several physiological processes, including
neuronal development (Böhm et al., 2008; Sakaki-Yumoto
et al., 2006; Tahara et al., 2019), limb formation (Akiyama et al.,
2015; Koshiba-Takeuchi et al., 2006), and gametogenesis
(Chan et al., 2017; Hobbs et al., 2012; Xu et al., 2017; Yamaguchi
et al., 2015). Deletion of the Sall4 gene leads to embryonic
lethality shortly after implantation (Sakaki-Yumoto et al., 2006;
Elling et al., 2006; Warren et al., 2007). In humans, failure of
SALL4 function is the cause of two severe developmental disor-
ders: the recessive genetic disorder Okihiro syndrome (Al-Bara-
die et al., 2002; Kohlhase et al., 2002) and embryopathies due to
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treatment during pregnancy with the drug thalidomide (Donovan
et al., 2018; Matyskiela et al., 2018). Despite its biological and
biomedical importance, the molecular functions of SALL4 are
incompletely understood. The extreme N terminus interacts spe-
cifically with the nucleosome remodeling and deacetylase
(NuRD) co-repressor complex and can account for the transcrip-
tional repression caused by SALL4 recruitment to reporter genes
(Lauberth and Rauchman, 2006; Lu et al., 2009). In addition,
there is evidence that the zinc-finger clusters bind to DNA (Sa-
kaki-Yumoto et al., 2006; Xiong et al., 2016) or protein partners
(Hobbs et al., 2012; Tanimura et al., 2013), though their precise
developmental roles are unclear. The present work demon-
strates thatmany of the defects seen inSall4 null ESCs, including
precocious differentiation, are mimicked by inactivation of a sin-
gle zinc-finger cluster that interacts with AT-rich motifs. We go
on to show that the ability of SALL4 to sense DNA base compo-
sition is essential to restrain transcription of genes that promote
differentiation.
RESULTS
A screen for AT-binding proteins in ESCs
identifies SALL4
To identify proteins able to sense base composition, we used a
DNA affinity purification approach coupled with stable isotope
labeling with amino acids in cell culture (SILAC) quantitative
mass spectrometry (Spruijt et al., 2013a, 2013b). Mouse ESC
protein extracts were mixed with double-stranded DNA probes
carrying variable runs of 5 base pairs composed only of A or T
nucleotides (AT-1 and AT-2). As a negative control, matched
probes with AT runs interrupted by G or C nucleotides were
used as bait (Ctrl-1 and Ctrl-2). To robustly assess DNA-binding
specificity, experiments were performed both in the ‘‘forward’’
(heavy-labeled AT probe versus light-labeled Ctrl-probe) and
‘‘reverse’’ (heavy-labeled Ctrl-probe versus light-labeled AT
probe) orientations, which were considered as biological repli-
cates. Proteins that bind specifically to AT runs show a high ratio
in the forward experiments (Figure 1A, x axes) and a low ratio in
the reverse experiments (Figure 1A, y axes). Mass spectrometry
identified a consistent set of AT-binding proteins that largely
overlapped between replicate experiments (Figure S1A) and be-
tween unrelated AT-rich probes (Figure S1B). High-confidence
hits included proteins with well-characterized AT-binding do-
mains such as AT hooks (Aravind and Landsman, 1998; Filarsky
et al., 2015) (HMGA1, HMGA2, PRR12, and BAZ2A) and ‘‘AT-rich
interaction domains’’ (Patsialou et al., 2005) (ARID3A, ARID3B,
and ARID5B), thereby validating the screen (Figure 1A; Table
S1). Three Spalt-like (SALL) family proteins (Sweetman and
M€unsterberg, 2006) (SALL1, SALL3, and SALL4) and most com-
ponents of the NuRD complex (Tong et al., 1998; Wade et al.,
1998; Xue et al., 1998; Zhang et al., 1998) were also recovered
(Figure 1A). The most consistently enriched protein in our mass
spectrometry screen was SALL4, whose AT binding we
confirmed by western blot analysis using a variety of probes
with one (AT-3) or more AT runs (Figure S1C). Considering their
reported interaction with NuRD (Lauberth and Rauchman,
2006), we suspected that SALL proteins might be responsible
for recruitment of this co-repressor complex to AT-rich DNA.
To test this, we used extracts from mouse ESCs in which the
Sall4 gene is disrupted (Sall4 knockout [S4KO] ESCs) (Sakaki-
Yumoto et al., 2006; Miller et al., 2016). As predicted, recovery
of NuRD components by AT-rich DNA was greatly reduced
compared towild type (WT) in the absence of SALL4 (Figure 1B).
SALL4 binds to short AT-richmotifs via C2H2 zinc-finger
cluster 4 (ZFC4)
Mammalian genomes encode four SALL family proteins
(SALL1–SALL4), which each contain several clusters of C2H2
zinc fingers. Based on similarities in amino acid sequence be-
tween family members, the clusters are classified as ZFC1–
ZFC4 (Figure 1C). SALL1, SALL3, and SALL4 all possess
ZFC4 (Figure S1D), but SALL2 lacks this domain and was not
recovered in our screen for AT-binding proteins. ZFC4 of both
SALL1 and SALL4 was previously shown to interact with AT-
rich heterochromatin in transfection assays (Sakaki-Yumoto
et al., 2006; Yamashita et al., 2007), suggesting that it might
be responsible for AT binding. To further characterize this
domain, we used CRISPR-Cas9 to either delete ZFC4
(ZFC4D) or mutate two residues (T919D and N922A; mutated
residues are shown in red) that we predicted would be involved
in DNA binding (ZFC4mut) (Figure 1D). Homozygous mouse
ESC lines expressing both mutated SALL4 proteins were ob-
tained (Figure S1E), both of which retained the ability to interact
with NuRD components by co-immunoprecipitation (Fig-
ure S1F). The interaction of SALL4 ZFC4mut or ZFC4D proteins
with AT-rich sequences was drastically reduced (>10-fold) by
inactivation of ZFC4, as assessed by the DNA pull-down assay
(Figure 1E). This strongly suggests that the ZFC4 domain of
SALL4 is primarily responsible for pull-down by AT-rich DNA.
We next explored the in vivo DNA-binding properties of
SALL4 ZFC4 in our mutant ESC lines. Heterochromatic foci,
identified by DAPI staining in mouse cells, contain a high con-
centration of AT-rich satellite DNA (Matsuda and Chapman,
1991; Cerda et al., 1999; Guenatri et al., 2004) and therefore
provide a low-resolution cellular assay for preferential AT bind-
ing. Immunostaining with a SALL4 antibody recognizing a pre-
served epitope in the two mutant proteins revealed a striking
loss of ZFC4mut and ZFC4D protein localization at DAPI-dense
foci (Figure 1F), further confirming that this zinc-finger cluster is
necessary for AT targeting.
To define the sequence preference of the purified ZFC4
domain, we performed systematic evolution of ligands by expo-
nential enrichment (SELEX) coupled with high-throughput
sequencing (HT-SELEX), whereby a library of initially random
DNA sequences immobilized on beads was subjected to
repeated cycles of binding and amplification (Jolma et al.,
2010; Nitta et al., 2015). After 0, 1, 3, or 6 cycles, DNA was
analyzed by high-throughput sequencing to detect enriched
motifs. For comparison, we performed HT-SELEX on other
SALL4 zinc-finger clusters (ZFC1 and ZFC2) (Figure 2A) and
also included a sample without added proteins to control for
PCR bias. Strikingly, with increasing cycles of ZFC4 binding,
the base composition of the whole library gradually shifted to-
ward higher AT content, but this effect was not seen with
ZFC1, ZFC2, or the negative control (Figure 2B). Progressive
A/T motif enrichment was also apparent for ZFC4 alone
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(Figure 2C). To determine the minimum number of A/T base
pairs required for enrichment, we separated the oligomers (k-
mers) into different groups (Figure 2C). Enrichment was only
detectable in k-mers containing 4 or more A/T base pairs, sug-
gesting that this is the minimum target sequence. After 6 cycles,





Figure 1. Identification of novel AT-binding proteins in ESCs by DNA pull-down mass spectrometry
(A) Scatterplots representing SILAC-based DNA affinity purifications, comparing AT-rich DNA probes (AT-1 and AT-2) with control probes having interrupted AT
runs (Ctrl-1 and Ctrl-2). The ratio of the quantified proteins in the forward experiment (Heavy-AT/Light-Ctrl) is plotted on the x axis, and the ratio for the same
proteins in the reverse experiment (Heavy-Ctrl/Light-AT) is plotted on the y axis. Proteins were considered to be specific interactors when showing at least a 2-fold
ratio in both the forward and reverse experiments. These proteins cluster in the bottom right quadrant.
(B) DNA pull-down with AT-rich (AT-2) or control (Ctrl-2) probes followed by western blot analysis for SALL4 and NuRD components usingwild-type (WT) or Sall4
knockout (S4KO) ESC protein extracts.
(C) Protein alignment of mouse SALL family members indicating conserved protein domains, including C2H2 zinc-finger clusters (ZFC1–ZFC4).
(D) Diagram showing the mutations or deletion introduced within SALL4 ZFC4 by CRISPR-Cas9.
(E) DNA pull-down with AT-rich (AT-3) or control (Ctrl-3) probe followed by western blot analysis for SALL4 using WT or Sall4 ZFC4mut/D ESC protein extracts.
SALL4 levels were quantified and normalized to input. Data points indicate independent replicate experiments and error bars standard deviation.
(F) SALL4 immunofluorescence in the indicated ESC lines. DNAwas stainedwith DAPI, showing dense clusters of AT-rich pericentric chromatin. Scale bars, 3 mm.
See also Figure S1 and Table S1.
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Figure 2. Characterization of SALL4 C2H2 zinc-finger cluster 4 (ZFC4) DNA binding in vitro and in vivo
(A) SALL4 ZFC1, ZFC2, and ZFC4 protein fragments used for in vitro HT-SELEX experiments. A sample without added protein was used as a negative control.
(B) Base composition of HT-SELEX libraries following 1, 3, and 6 cycles with ZFC1 (dark gray), ZFC2 (light gray) and ZFC4 purified proteins (blue).
(C) Relative enrichment of 5-mer motifs categorized by AT content at cycles 0, 1, 3, and 6 of HT-SELEX with SALL4 ZFC1 (dark gray), ZFC2 (light gray), ZFC4
(blue), and negative control (black) samples. All 16 possible A/T 5-mer motifs are ordered according to their enrichment at cycle 6 of ZFC4 HT-SELEX.
(D) Venn diagram showing the overlap of SALL4 ChIP-seq peaks between WT and ZFC4mut ESCs.
(E) Profile plot and heatmap showing SALL4 ChIP-seq signal at SALL4 WT ChIP-seq peaks in the indicated cell lines.
(F) Venn diagram showing the overlap of SALL4 ChIP-seq peaks detected in WT ESCs with ATAC-seq peaks (accessible chromatin) and CpG islands.
(G) Results from de novomotif analysis at SALL4WT ChIP-seq peaks (summit ±250 bp) showing the relative frequency of each DNA motif and its associated E-
value. ATAC-seq peaks were used as a control for regions of accessible chromatin.
(H) Analysis of the DNA base composition surrounding SALL4 ChIP-seq peaks (summit ±250 bp) inWT (blue) and ZFC4mut (red) ESCs. CpG islands and ATAC-
seq peaks coincide with regions of accessible chromatin and are shown for comparison.
See also Figure S2.
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which also corresponds to the preferred sequence identified by
DNA pull-down using all possible combinations of AT 5-mers
(Figure S2B). However, this is one of several target sequences,
as multiple other AT-rich sequences had similar enrichment
scores (Figures 2B and S2A). All 16 possible A/T 5-mers are en-
riched more than G/C containing 5-mers, with k-mers contain-
ing TATA among the least favored AT-rich motifs for ZFC4 bind-
ing. We conclude that ZFC4 targets a broad range of short
motifs that are composed only of A and T, whereas ZFC1 and
ZFC2 showed no apparent DNA sequence specificity.
ZFC4 mutation drastically reduces SALL4 chromatin
binding in vivo
To assess the influence of ZFC4 on SALL4 chromatin occupancy
in vivo, we performed chromatin immunoprecipitation
sequencing (ChIP-seq) using two anti-SALL4 antibodies (one
monoclonal and one polyclonal) recognizing a C-terminal
epitope that is distant from C2H2 zinc-finger clusters. We first
determined antibody specificity (Kidder et al., 2011; Landt
et al., 2012; Uhlen et al., 2016) by assessing SALL4 ChIP signal
in S4KO ESCs as a negative control. Over 15,000 nonspecific
ChIP-seq peaks were observed with the polyclonal anti-SALL4
antibody compared with only 280 peaks for the monoclonal anti-
body (Figures S2C and S2D). We therefore analyzed exclusively
data obtained with the anti-SALL4monoclonal antibody, consid-
ering only ChIP-seq peaks that were consistent between inde-
pendent replicate experiments in WT or ZFC4mut ESCs (Fig-
ure S2E). In agreement with its reported localization at
enhancers (Miller et al., 2016; Xiong et al., 2016), we observed
that SALL4 ChIP-seq peaks inWT cells were enriched in the his-
tone marks H3K27ac and H3K4me1 (Chronis et al., 2017), which
typically mark these genomic sites (Figure S2F). Strikingly,
ZFC4mut cells lost 95% of ChIP-seq peaks compared to WT
(Figure 2D). Heatmaps confirmed the depletion of SALL4 peaks,
although we noted a small amount of bound ZFC4mut at a sub-
set of WT binding sites (Figure 2E).
We compared WT SALL4-binding sites as a whole with re-
gions of open chromatin identified by assay for transposase-
accessible chromatin with high-throughput sequencing
(ATAC-seq), which detects accessible DNA, including en-
hancers and promoters. SALL4 peaks largely coincide with a
subset of ATAC-seq peaks, while avoiding CpG island pro-
moters (Figure 2F). The AT-binding specificity of SALL4 sug-
gests that this protein might preferentially associate with
open chromatin sites that are more AT rich than average.
The complete absence of SALL4 at ATAC-seq peaks within
CpG islands (Figure 2F), within which runs of As and Ts are
rare, is compatible with this notion. To quantify this effect,
we used de novo motif analysis to determine whether SALL4
peaks were consistent with a bias toward AT-rich motifs. First,
by seeking recurrent motifs (<8 base pairs) coincident with
SALL4 peaks, we identified short AT-rich motifs that were
highly enriched at the majority (90%) of SALL4-binding sites
compared with lower levels of enrichment (60%) in open
chromatin generally (Figure 2G). As a second approach, we
determined the base composition at SALL4-bound regions
by analyzing the DNA sequences surrounding SALL4 ChIP-
seq peak summits (±250 bp). SALL4 binding sites are relatively
AT rich (50%–70% AT) (Figure 2H) compared with ATAC-seq
peaks as a whole (40%–60% AT) (Figure 2H). Taken together,
the data suggest that AT-motif binding is responsible for the
presence of SALL4 at a subset of open chromatin sites.
SALL4 ZFC4 represses the expression of early
differentiation genes in a base-composition-dependent
manner
To determine whether SALL4 binding to AT-rich DNA causes
gene expression changes that correlate with base composition,
we performed RNA sequencing (RNA-seq) in WT, ZFC4mut,
ZFC4D, and S4KO ESCs. Sall4 gene knockout resulted in the
dysregulation of several thousand genes (Figure 3A). Both
ZFC4 mutations caused the dysregulation of fewer genes,
many of which overlappedwith those affected inS4KO cells (Fig-
ure 3A). To test the relationship between AT composition and
gene expression, genes differentially regulated in both ZFC4mut
and ZFC4D ESCs (Figure 3A, red filling) were divided into five
equal categories according to AT content across the entire tran-
scription unit (Figure 3B), and the level and direction of transcrip-
tional change was compared between them. In agreement with
our hypothesis, genes differentially regulated in ZFC4mut/D cells
showed progressively increased upregulation with rising AT con-
tent (Figure 3C). To quantify the strength of the relationship
between AT content and gene expression, we fitted a linear
regression model and calculated coefficient estimates. This in-
dependent approach, which reveals the variation in gene expres-
sion that can be attributed to base composition, confirmed that
the positive relationship between AT content and upregulation in
the ZFC4 mutants is significant (false discovery rate [FDR] <
0.01; see STAR methods; Table S2; Figure S3A). In contrast,
genes differentially regulated in S4KO, but not in either of the
ZFC4 mutant ESCs (Figure 3A, gray filling), showed a nonsignif-
icant correlation (FDR > 0.01) and an effect size close to zero
(Figures 3D, S3B, and S3C). The results show that the subset
of SALL4-regulated genes that is dependent on ZFC4 is
repressed in pluripotent cells according to the AT richness of
their genomic setting.
To further test the hypothesis that AT binding by ZFC4 medi-
ates repression according to base composition, we examined
the reverse situation of SALL4 overexpression on transcription.
This was performed by expressing SALL4, or as a negative con-
trol enhanced green fluorescent protein (EGFP), from a doxycy-
cline-inducible promoter following random integration of expres-
sion constructs inS4KOESCs (Figure 3E). After 48 h of induction,
SALL4 was robustly overexpressed in these cells (Figures S3D
and S3E). To characterize the effect of SALL4 reexpression on
transcription, we performed RNA-seq on induced (+Dox) and
noninduced (Dox) cell lines (Figure 3F). As expected, gene
expression changes in cells overexpressing SALL4 were anticor-
related with expression changes seen in S4KO cells (Figure S3F).
Separation of differentially expressed genes into categories ac-
cording to their AT content as before revealed that SALL4
expression caused transcriptional repression that was strikingly
proportional to the base composition of the affected genes (Fig-
ures 3G and S3G). A similar relationship was observed when
looking at genes differentially regulated in ZFC4mut/D ESCs
(Figure 3H). Linear regression analysis again confirmed the
ll
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Figure 3. SALL4-mediated transcriptional regulation in relation to DNA base composition
(A) Venn diagram showing the overlap of differentially expressed genes detected by RNA-seq among S4KO, ZFC4mut, and ZFC4D ESCs. ZFC4-regulated genes
are indicated in red and ZFC4-independent genes in gray.
(B) Profile plot showing the density of A/T nucleotides around the transcription unit of ZFC4-regulated genes divided into five equal categories according to AT
content. TSS, transcription start site; TES, transcription end site.
(C and D) Correlation between genemis-regulation (log2 fold change versusWT) and DNA base composition inSall4mutant ESCs. ZFC4-regulated (C) and ZFC4-
independent (D) genes were divided into five equal categories depending on their AT content.
(E) Diagram representing S4KO ESC lines carrying SALL4 or EGFP (control) expression constructs under control of a doxycycline-inducible promoter.
(F) Venn diagram showing the overlap of differentially expressed genes detected by RNA-seq following a 48-h doxycycline induction in the ESC lines presented in
(E). SALL4-responsive genes are indicated in blue and EGFP-responsive genes in green.
(G and H) Correlation between SALL4-induced gene expression changes and DNA base composition. SALL4-responsive (G) and ZFC4-regulated (H) genes were
divided into five equal categories depending on their AT content, and their relative expression levels were analyzed in the indicated ESC lines.
(I) Diagram showing the protocol used to characterize early differentiation of WT ESCs.
(J) Venn diagram showing the overlap between genes changing during early differentiation ofWT cells (day 0 versus day 2) with genes de-regulated inSall4mutant
ESCs. Genes were divided into three categories: SALL4-independent genes (light blue), SALL4-dependent genes controlled by ZFC4 (red), and SALL4-
dependent genes not controlled by ZFC4 (gray).
(K) Correlation between gene expression changes occurring during early differentiation and DNA base composition inWT cells. SALL4-independent genes (light
blue), SALL4-dependent genes controlled by ZFC4 (red), and SALL4-dependent genes not controlled by ZFC4 (gray) were divided into five equal categories
depending on their AT content, and their relative expression levels were analyzed at day 2 of differentiation.
See also Figure S3 and Tables S2 and S3.
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significance of these relationships (Figures S3H and S3I). As a
control, we applied the same analysis to the minority of genes
whose expression was altered in response to EGFP induction
(Figure 3F, green filling). In this case, there was no apparent rela-
tionship between fold change and base composition (Figures
S3J and S3K), as confirmed by quantitative analysis (Figure S3L).
Together, our results strongly suggest that SALL4 directly regu-
lates gene expression in response to base composition via its
zinc-finger cluster, ZFC4.
Interestingly, Gene Ontology (GO) analysis of ZFC4-regu-
lated genes identified GO terms associated with neuronal dif-
ferentiation, morphogenesis, gonad development, and kidney
development (Table S3), all of which are adversely affected in
S4KO mice and embryos (Sakaki-Yumoto et al., 2006; Böhm
et al., 2008; Tahara et al., 2019; Koshiba-Takeuchi et al.,
2006; Akiyama et al., 2015; Hobbs et al., 2012; Yamaguchi
et al., 2015; Xu et al., 2017; Chan et al., 2017; Warren et al.,
2007). This suggests the possibility that SALL4 plays an essen-
tial role in the transition between self-renewing ESCs and the
differentiated state by preferentially suppressing the expres-
sion of AT-rich developmental genes, thus preventing prema-
ture loss of pluripotency. If so, AT-rich genes that are aber-
rantly upregulated in the absence of ZFC4 should be
activated during the normal differentiation program ofWT cells
(Rao et al., 2010). To test this, we performed RNA-seq on WT
ESCs following 2 days of monolayer differentiation (Figure 3I)
(Aubert et al., 2002). Although they represent a small fraction
of all transcriptional changes taking place at these stages,
SALL4-regulated genes overlapped significantly with genes
whose expression changes naturally between day 0 (ESCs)
and day 2 of differentiation (Figure 3J). Importantly, ZFC4-
regulated genes, but not other categories of genes, are upre-
gulated at this early stage in proportion to AT richness (Figures
3K, S3M, and S3N). Thus, AT-rich genes that are repressed by
SALL4 in ESCs are activated soon after the exit from
pluripotency.
SALL4 ZFC4 is critical for neuronal differentiation and
embryonic development
Previous work demonstrated that disruption of the Sall4 gene
leads to increased stem cell differentiation (Yuri et al., 2009;
Miller et al., 2016). To test whether disrupting ZFC4 alone
leads to phenotypic defects, we compared ZFC4mut and
S4KO ESCs. Consistent with previous evidence showing that
SALL4 is dispensable for the maintenance of pluripotency (Sa-
kaki-Yumoto et al., 2006; Yuri et al., 2009; Tsubooka et al.,
2009), both S4KO and ZFC4mut ESCs expressed normal
levels of OCT4 (Figure S4A) and showed efficient self-renewal,
with a modest decrease observed in S4KO ESCs (Figure S4B).
Next, we used a monolayer differentiation assay, as described
above, to assess the propensity of these cell lines to acquire a
neuronal fate. After 5 days in N2B27 medium, ESCs lacking
SALL4 or expressing a ZFC4 mutant protein generated many
more TUJ1-positive cells compared to WT cells (Figure 4A).
Further confirming increased neuronal differentiation, qRT-
PCR analyses identified increased transcription of Tuj1 (4- to
12-fold), Ascl1 (3- to 6-fold), and Nestin (2-fold) in S4KO,
ZFC4mut, and ZFC4D ESCs at day 5 of differentiation (Fig-
ure 4B). By this assay, inactivation of ZFC4 phenocopies com-
plete loss of SALL4 protein.
In order to observe the effects of ZFC4 mutation on embry-
onic development, we generated a ZFC4mut mouse line by
blastocyst injection of heterozygous Sall4ZFC4mut/WT ESCs. F1
mice were crossed and their progeny analyzed at different
stages of development. While ZFC4mut homozygous embryos
were obtained at Mendelian ratios during early development,
none survived until birth (Figures 5A and 5B). By embryonic
day 10.5 (E10.5), homozygous embryos presented gross
morphological abnormalities, which were not observed in con-
trols (Figure 5C). Importantly, the ZFC4mut protein was ex-
pressed at levels similar to those seen in WT embryos (Figures
S5A and S5B). Early embryonic mortality of ZFC4 mutant mice
is reminiscent of the phenotype observed in S4KO mice,
although the latter die earlier in development, shortly after im-
plantation (by E5.5–E6.5) (Elling et al., 2006; Sakaki-Yumoto
et al., 2006). Taken together, our in vitro and in vivo experiments
indicate that mutation of ZFC4 alone phenocopies important as-
pects of the S4KO phenotypes seen in both ESCs and embryos.
It follows that this DNA-binding domain is a key contributor to
SALL4 biological function.
C2H2 zinc-finger clusters ZFC1 and ZFC2 are
dispensable for SALL4 function in ESCs
SALL4 contains two C2H2 zinc-finger clusters, ZFC1 and
ZFC2, in addition to ZFC4. To determine their contribution to
SALL4 function, we used CRISPR-Cas9 to delete the central
segment of endogenous SALL4 protein, which contains the
zinc-finger clusters ZFC1 and ZFC2, while leaving ZFC4 and
the N-terminal domain intact (Figure 6A). ESCs homozygous
for this ZFC1-2D knockin allele lack full-length SALL4, but, as
expected, ZFC1-2D protein retained the ability to interact
with SALL1 and NuRD components (Figure S6A). Immuno-
staining showed that ZFC1-2D resembled WT SALL4 by being
enriched at heterochromatic foci, indicating that ZFC4 binding
to this AT-rich DNA in vivo is unaffected by the internal deletion
(Figure 6B). To characterize ZFC1-2D chromatin binding in
more detail, we performed ChIP-seq (Figure S6B), as
described above. In contrast to the dramatic effect of ZFC4
inactivation on SALL4 ChIP-seq peaks, ZFC1-2D occupancy
of the genome closely resembled that of WT SALL4 (Fig-
ure S6C). In addition, both the average ChIP-seq signal (Fig-
ure 6C) and AT-rich profile (Figure 6D) of WT SALL4 peaks
were preserved in ZFC1-2D cells. We conclude that ZFC1
and ZFC2 contribute minimally to the genome binding profile
of SALL4, further supporting the view that ZFC4 is the primary
determinant of DNA binding. Comparative RNA-seq analysis
between WT, ZFC4mut, and ZFC1-2D ESCs revealed that
SALL4 ZFC1-2D and ZFC4mut affect largely nonoverlapping
sets of genes (Figure 6E). The effects of ZFC1-2D on transcrip-
tion were independent of base composition, whereas ZFC4
regulated genes in proportion to their AT richness (Figure 6F,
S6D, S6E and S6F). Finally, we examined the phenotypic con-
sequences of ZFC1-2 deletion by assayingmonolayer neuronal
differentiation of our mutant ESCs. Unlike S4KO and ZFC4mut
ESCs, ZFC1-2D cells did not show evidence of increased dif-
ferentiation as assessed by TUJ1 immunofluorescence
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(Figure 6G) and RT-qPCR analysis of neuronal markers at day 5
of differentiation (Figure S6G).
To further characterize the differentiation defects of Sall4
mutant ESCs, we performed an RNA-seq time-course experi-
ment with WT, S4KO, ZFC4mut, and ZFC1-2D cell lines at
days 0 (ESCs), 2, and 5 of the differentiation protocol (Fig-
ure 7A). In agreement with our previous base-composition an-
alyses, absence of SALL4 or inactivation of ZFC4 weakened
repression, leading to premature activation of ZFC4-regulated
AT-rich genes at all differentiation time points (Figure S7A). In
contrast, ZFC1/2-regulated genes showed no preferential up-
regulation during differentiation and no correlation with base
composition in any of the cell lines (Figure S7B). Moreover,
principal-component analysis (PCA) showed that WT and
ZFC1-2D samples clustered together at all time points, while
S4KO and ZFC4mut formed an independent cluster at days
2 and 5 (Figure S7C). Accordingly, differential expression anal-
ysis across our time series revealed few differences between
WT and ZFC1-2D, while the transcriptomes of S4KO and
ZFC4mut were significantly disturbed (Figure 7B). Empha-
sizing the similarity of S4KO and ZFC4mut, genes differentially
regulated in these cell lines were highly correlated both at day
2 and day 5 of differentiation (Figures 7C and S7D). Also,
genes associated with neuronal differentiation were upregu-
lated in both cell lines, whereas expression of these genes in
ZFC1-2D cells was unaffected (Figure 7D). We conclude that
the characteristic premature differentiation phenotype associ-
ated with SALL4 deficiency is mimicked by inactivation of
ZFC4, but not by a large deletion of the central domain that in-
cludes ZFC1 and ZFC2.
DISCUSSION
SALL4 targets a broad range of AT-rich motifs via the zinc-finger
cluster ZFC4. While the ZFC4 domain has previously been impli-
cated in binding to AT-rich repetitive DNA found in mouse major
satellite (Yamashita et al., 2007), its biological significance was
unknown. Our study demonstrates that ZFC4 is a key domain
mediating SALL4 biological function in ESCs. Its inactivation
drastically reduces peaks of SALL4 binding to the genome, sug-
gesting that this domain plays a critical role in SALL4 targeting to
chromatin. Disruption of the genomic binding pattern is
A B
Figure 4. Phenotypic effects of SALL4 ZFC4 mutation on neuronal differentiation
(A) TUJ1 immunofluorescence in the indicated ESC lines cultured in serum/leukemia inhibitory factor (LIF) medium, and following differentiation for 5 days in
N2B27 medium. DNA was stained with DAPI. Scale bars, 100 mm.
(B) qRT-PCR analysis of the neuronal markers Tuj1, Ascl1, and Nestin in the indicated cell lines following differentiation for 5 days in N2B27 medium. Transcript
levels were normalized to TATA-binding protein (TBP) and expressed relative to WT. Data points indicate independent replicate experiments and error bars
standard deviation.
See also Figure S4.
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accompanied by mis-regulation of a subset of all SALL4-regu-
lated genes, many of which are implicated in neuronal differenti-
ation, which is the preferred fate of ESCs in culture. Accordingly,
ESCs expressing SALL4 lacking a functional ZFC4 domain phe-
nocopy S4KO ESCs by displaying precocious differentiation to-
ward the neuronal lineage. Importantly, we found that this gene
set is normally activated as WT ESCs commence differentiation
in culture to give neurons, a process that coincides with downre-
gulation of SALL4 protein (Rao et al., 2010). The importance of
ZFC4 is further demonstrated by the embryonic lethal phenotype
of ZFC4mut homozygotes.
Levels of ZFC4 mutant proteins are somewhat reduced in the
mutant ESCs (50%–75% of WT), but we consider it unlikely that
this contributes to the biased effect on expression of AT-rich
genes. The changes in genome occupancy revealed by ChIP
and immunostaining are much greater than 2-fold and are un-
likely to be due to the relatively modest reduction in protein
levels. In addition, the early embryonic lethality of the ZFC4 mu-
tation is much more severe than that seen in mice heterozygous
for the Sall4 KO allele, which can be viable and fertile despite
having 50% less protein (Sakaki-Yumoto et al., 2006). Notably,
the reduction in ZFC4mut protein seen in ESCs is not repro-
duced in mouse embryos, as mutant and WT proteins are pre-
sent at indistinguishable levels, yet the phenotype is neverthe-
less extremely severe. On the other hand, loss of the only AT-
binding domain in the protein offers an attractive explanation
for this phenomenon. Human genetics provides further support
for the central importance of ZFC4. Mutations in the SALL4
gene cause Okihiro syndrome (Al-Baradie et al., 2002; Kohlhase
et al., 2002; Terhal et al., 2006), with most patients carrying
frameshift or nonsense mutations leading to deletion or severe
truncation of the protein. The only reported disease-causing
missense mutation (H888R) affects a zinc-coordinating histidine
that is expected to specifically inactivate ZFC4 (Miertus et al.,
2006), although this has not been tested experimentally.
Evidence regarding the functional significance of two other
zinc-finger clusters, ZFC1 and ZFC2, is limited, although an affin-
ity of ZFC1 for hydroxymethylcytosine has been reported (Xiong
et al., 2016). Importantly, simultaneous deletion of ZFC1 and
ZFC2 has a minimal effect on genome occupancy, gene expres-
sion, and propensity to differentiate of ESCs. Thus, the well-
known role of SALL4 in stabilization of the pluripotent state
appears to be largely attributable to the DNA-binding specificity
of ZFC4. Our observations agree with previous studies using
transfection assays that indicated that the naturally occurring
isoform SALL4B, which closely resembles ZFC1-2D in lacking
ZFC1 and ZFC2 and is expressed at much lower levels than
the full-length SALL4A form, retains biological activity in pluripo-
tent cells (Rao et al., 2010; Miller et al., 2016). Although these re-
sults suggest that these two C2H2 zinc-finger clusters are
dispensable for SALL4 function in ESCs, we note that their
sequence is highly conserved between fruit flies and humans.
It is therefore likely that ZFC1 and ZFC2 are functional in other
developmental contexts, such as limb development and/or
gametogenesis.
At first sight, the correlation with base composition across
the extended transcription unit contrasts with the relatively
sharp peaks of SALL4 binding observed by ChIP-seq. In
fact, it remains to be determined whether SALL4 acts at dis-
tance from AT-rich motifs in discrete regulatory elements or
by binding broadly to AT-rich sequences dispersed through
gene bodies. The latter would be challenging to detect by
A C
B
Figure 5. Mutation of SALL4 ZFC4 causes embryonic lethality
(A) Table showing the number of live pups and embryos at different stages of development and their associated genotype. Animals were crossed to obtain
ZFC4mut heterozygous (Het), homozygous (Hom), or WT progeny.
(B) Diagram showing the results from crossing ZFC4mut heterozygote mice. ZFC4mut homozygous animals die during embryonic development.
(C) Representative images of WT, ZFC4mut heterozygous (Het), and homozygous (Hom) embryos at E10.5, taken at the same magnification.
See also Figure S5.
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ChIP due to the high abundance of AT-rich motifs throughout
the genome (potentially in excess of 10 million target sites) in
contrast with the low abundance of SALL4 protein in ESCs
(2,000–3,000 copies per cell) (Zhang et al., 2017). As a result
of this discrepancy, percent occupancy of any one target
site is likely to be extremely low. Further work is required to
distinguish the effects on gene expression of dispersed versus
focal SALL4 binding. An obvious potential mediator of repres-
sion by SALL4 is the NuRD co-repressor complex, which has
long been known to associate with the N terminus of SALL4
(Lauberth and Rauchman, 2006). The role of NuRD recruitment





Figure 6. Effects of SALL4 ZFC1 and ZFC2 deletion in ESCs on chromatin binding, gene expression, and differentiation
(A) Diagram showing the in-frame deletion within the Sall4 coding sequence, generated by CRISPR-Cas9.
(B) SALL4 ZFC1-2D localization determined by immunofluorescence in the indicated ESC lines. DNA was stained with DAPI, showing dense clusters of AT-rich
pericentric chromatin. Scale bars, 3 mm.
(C) Heatmap and profile plot showing SALL4 ChIP-seq signal at SALL4 WT ChIP-seq peaks in the indicated cell lines.
(D) Analysis of the DNA base composition surrounding SALL4 ChIP-seq peaks (summit ±250 bp) in WT (blue) and ZFC1-2D (purple) ESCs.
(E) Venn diagram showing the overlap of differentially expressed genes detected by RNA-seq between ZFC4mut and ZFC1-2D ESCs. ZFC4-regulated genes are
indicated in red and ZFC1/2-regulated genes in purple.
(F) Correlation between gene mis-regulation (log2 fold change versus WT) and DNA base composition in Sall4 mutant ESCs. ZFC4-regulated (red) and ZFC1/
2-regulated (purple) genes were divided into five equal categories depending on their AT content.
(G) TUJ1 immunofluorescence in the indicated ESC lines cultured in serum/LIF medium and following differentiation for 5 days in N2B27 medium. DNA was
stained with DAPI. Scale bars, 100 mm.
See also Figure S6 and Table S2.
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2016). Another poorly understood aspect of SALL4 biochem-
istry is its interaction with other members of the SALL family
(Kiefer et al., 2003; Sweetman et al., 2003). Notably, our
screen for AT-binding proteins also identified SALL1 and
SALL3, which both interact with SALL4 and might contribute
to sensing AT content via their closely similar ZFC4 domains.
Given the importance of SALL4 in development and disease,
these issues deserve further investigation.
Our results demonstrate that cell-type-specific genes residing
within AT-rich domains are susceptible to repression by the tran-
scriptional repressor, SALL4, thereby preventing differentiation.
Vertebrate genomes are on average relatively AT rich (60% A/T),
and therefore, the short A/T motifs to which it binds occur
throughout the genome with frequencies that vary probabilisti-
cally according to local base composition. As base composition
is a constant feature of the genome, regulation is achieved by
varying the availability of the base composition reader itself.
Accordingly, as cells enter differentiation, expression of SALL4
drops (Rao et al., 2010), raising the possibility that differentiation
is triggered by loss of SALL4-mediated inhibition of key develop-
mental genes. Global regulation of this kind confers the ability to
modulate expression of multi-gene blocks using relatively few
base composition readers and is potentially more economical
than controlling each gene by a separate mechanism. Our
finding that this relatively simple systemmay underlie large-scale
switching of gene expression programs indicates that base
compositional domains are not merely a biologically irrelevant
byproduct of genome evolution but constitute a signal that is ad-
vantageous to the organism.
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Figure 7. Transcriptional effects of SALL4 zinc-finger cluster mutations during neuronal differentiation
(A) Diagram of the RNA-seq time-course experiment comparing the differentiation potential of WT and Sall4 mutant ESCs.
(B) Differential gene expression analysis betweenWT andSall4mutant cell lines during neuronal differentiation at days 2 and 5 (adjusted p value < 0.05). Additional
WT replicates were used as a control (WT versus WT).
(C) Scatterplot showing the relative expression levels of genes deregulated in differentiating S4KO cells (see B, gray bars) correlating with their expression in
ZFC4mut cells at days 2 and 5 of differentiation.
(D) Relative expression levels (log2 fold change versusWT) of genes associated with the GO term ‘‘positive regulation of neuron differentiation’’ (GO:0045666) in
Sall4 mutant cell lines at days 2 and 5 of differentiation. Additional WT replicates were used as a control (WT versus WT). Stars indicate statistical significance
calculated from bootstrapped two-sided t tests (p value < 0.05).
See also Figure S7 and Table S2.
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STAR+METHODS
KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
SALL4 Abcam ab29112; RRID: AB_777810
SALL4 Santa Cruz Biotechnology sc-101147; RRID: AB_1129262
CHD4 Abcam ab70469; RRID: AB_2229454
MTA1 Santa Cruz Biotechnology sc-9446; RRID:AB_649545
MTA1 Santa Cruz Biotechnology sc-373765; RRID: AB_10917039
SALL1 Abcam ab41974; RRID: AB_777807
GATAD2A Abcam ab87663; RRID: AB_1952305
MBD3 Bethyl A302-528A; RRID: AB_1998980
HDAC1 Santa Cruz Biotechnology sc-6298; RRID: AB_2279712
HDAC1 Santa Cruz Biotechnology sc-81598; RRID: AB_2118083
OCT4 Abcam ab19857; RRID: AB_445175
TUJ1 BioLegend 801201; RRID: AB_2313773
Chemicals, peptides, and recombinant proteins
Recombinant ZFC4 (SALL4 residues
859-1028)
This paper N/A
Recombinant ZFC1 (SALL4 residues
320-486)
This paper N/A




KAPA RNA Hyperprep Kit with RiboErase
(RNA-seq library preparation)
Roche 08098131702




Raw and processed data used to generate
the Figures
This paper Mendeley Data: https://doi.org/10.17632/
rwzttj9pn2.1
RNA-seq of WT, S4KO, ZFC4mut and
ZFC4D ESCs
This paper Array Express: E-MTAB-7343
RNA-seq of WT, S4KO, ZFC4mut and
ZFC1-2D ESCs
This paper Array Express: E-MTAB-7655
ChIP-seq of anti-SALL4 in WT, S4KO,
ZFC4mut and ZFC1-2D ESCs
This paper Array Express: E-MTAB-9197
Time-course (day 0, 2 and 5) RNA-seq of
WT, S4KO, ZFC4mut and ZFC1-2D ESCs
This paper Array Express: E-MTAB-9198
RNA-seq of S4KO cells integrated with
Sall4 cDNA or EGFP cDNA with a
doxycycline inducible promoter
This paper Array Express: E-MTAB-9202
HT-SELEX of recombinant C2H2 zinc finger
domains of SALL4
This paper Array Express: E-MTAB-9236
ATAC-seq in WT ESCs This paper Array Express: E-MTAB-9245
ChIP-seq of H3K4me1 and H3K27ac in
WT ESCs
Chronis et al., 2017 Gene Expression Omnibus: GSE90893
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Experimental models: cell lines
Mouse: Wild-type embryonic stem cell line;
E14Ju09
Hooper et al., 1987 N/A
Mouse: Sall4 knockout embryonic stem
cell line
Provided by Brian Hendrich laboratory
(Miller et al., 2016)
N/A
Mouse: Sall4 ZFC4mut embryonic stem
cell line
This paper N/A
Mouse: Sall4 ZFC4D embryonic stem
cell line
This paper N/A
Mouse: Sall4 ZFC1-2D embryonic stem
cell line
This paper N/A
Mouse: Sall4 knockout embryonic stem cell
line with doxycycline-inducible Sall4
construct
This paper N/A
Mouse: Sall4 knockout embryonic stem cell




Mouse: Sall4 ZFC4mut This paper N/A
Oligonucleotides
DNA pulldown oligonucleotides This paper; see Table S1 N/A
CRISPR/Cas9 oligonucleotides and
genotyping primers
This paper; see Table S1 N/A
RT-qPCR primers This paper; see Table S1 N/A
HT-SELEX oligonucleotides This paper; see Table S1 N/A
Recombinant DNA
Cas9/gRNA expression plasmid Ran et al., 2013 Addgene PX330
PiggyBac vector with doxycycline-
inducible construct and Hygromycin
resistance cassette
This paper N/A
PiggyBac vector with constitutively





Yusa et al., 2011 N/A
Software and Algorithms
Logolas Dey et al., 2018 N/A
sailfish v0.9.2 Patro et al., 2014 N/A
DESeq2 v1.28.0 Love et al., 2014 N/A
bedtools nuc Quinlan and Hall, 2010 N/A
deepTools Ramı́rez et al., 2014 N/A
clusterProfiler Yu et al., 2012 N/A
Trimmomatic v0.33 Bolger et al., 2014 N/A
bwa-mem v0.7.17 Li, 2013) N/A
Picard toolkit http://broadinstitute.github.io/picard/ N/A
computeGCBias Benjamini and Speed, 2012 N/A
MACS v2.1.2 Zhang et al., 2008 N/A
MEME-ChIP v5.1.0 Machanick and Bailey, 2011 N/A
Bioinformatics analysis – command line
arguments
This paper (Methods S1) N/A
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RESOURCE AVAILABILITY
Lead contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Adrian
Bird (a.bird@ed.ac.uk).
Materials availability
Reagents generated in this study are available upon request from the Lead Contact.
Data and code availability
Raw and processed high-throughput sequencing data was deposited on Array Express, as described in the Table below. Python
scripts and source code used for bioinformatic analyses, raw western blot and microscopy images, as well as other types of unpro-
cessed and processed data used to generate the figures are available on Mendeley Data (https://doi.org/10.17632/rwzttj9pn2.1).
For H3K4me1 and H3K27ac ChIP-seq in ESCs, previously published data were obtained from GEO (accession number:
GSE90893).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
In vivo animal studies (mouse)
The Sall4 ZFC4mut mouse line was generated by injection of CRISPR/Cas9-targeted heterozygous ESCs (see section above) into
mouse blastocysts using standard methods. Resultant male and female chimeras were crossed with C57BL/6J wild-type animals
at 7 weeks and coat color was used to identify germline offspring. Transmission of the targeted allele was confirmed by PCR (see
primers) and Sanger sequencing. Heterozygotes identified from these crosseswere inter-crossed to generate homozygotes. Animals
were routinely genotyped by PCR combined with restriction fragment length polymorphism (RFLP) analysis using HaeII (restriction
site introduced within ZFC4mut allele). Heterozygosity had no discernible phenotype in either sex at any age. The sex of homozygous
blastocysts and embryos was not determined post-mortem.
All mice used in this study were bred andmaintained at the University of Edinburgh animal facilities under standard conditions, and
procedures were carried out by staff licensed by the UK Home Office and in accordance with the Animal and Scientific Procedures
Act 1986 following initial approval by a local Animal Welfare and Ethical Review Board. All mice were housed within a SPF facility.
They were maintained on a 12h light/dark cycle and given ad libitum access to food and water. They were housed in open top cages
with wood chippings, tissue bedding and additional environmental enrichment in groups of up to ten animals. Mutant mice were
caged with their wild-type littermates.
In vitro cell culture studies (mouse)
Cell culture conditions
E14Ju09, a clonal cell line derived from E14Tg2a ESCs (Hooper et al., 1987), was used as a wild-type cell line in this study. Sall4
ZFC4mut, ZFC4D, and ZFC1-2D ESC lines were derived from E14Ju09 ESCs using CRISPR/Cas9, as indicated below. Sall4
Accession Description
E-MTAB-7343 RNA-seq of WT, S4KO, ZFC4mut and
ZFC4D ESCs
E-MTAB-7655 RNA-seq of WT, S4KO, ZFC4mut and
ZFC1-2D ESCs
E-MTAB-9197 SALL4 ChIP-seq in WT, S4KO, ZFC4mut
and ZFC1-2D ESCs
E-MTAB-9198 Time course RNA-seq during differentiation
(day 0, 2 and 5) ofWT, S4KO, ZFC4mut and
ZFC1-2D ESCs
E-MTAB-9202 RNA-seq of S4KO cells carrying Sall4 cDNA
or EGFP cDNA under a doxycycline
inducible promoter
E-MTAB-9236 HT-SELEX of recombinant C2H2 zinc-finger
domains of SALL4
E-MTAB-9245 ATAC-seq in WT ESCs
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knockout ESCs were kindly provided by Brian Hendrich (Cambridge University) with agreement of Riuchi Nishinakamura (Kumamoto
University) (Miller et al., 2016). SALL4 and EGFP doxycycline-inducible ESC lines were derived from Sall4 knockout ESCs using the
PiggyBac (PB) transposon system, as indicated below.
All ESC lines were incubated at 37C and 5% CO2 in gelatin-coated dishes containing Glasgow minimum essential medium
(GMEM; GIBCO ref. 11710035) supplemented with 15% fetal bovine serum (batch tested), 1x L-glutamine (GIBCO ref. 25030024),
1x MEM non-essential amino acids (GIBCO ref.11140035), 1mM sodium pyruvate (GIBCO ref. 11360039), 0.1mM 2-mercaptoetha-
nol (GIBCO ref. 31350010) and 100U/ml leukemia inhibitory factor (LIF, batch tested).
To differentiate ESCs into neurons, we performed monolayer neuronal differentiation (Aubert et al., 2002). ESCs were washed
with PBS, dissociated using Accutase (StemPro ref. A1110501) and resuspended in N2B27 medium: 1:1 mix of Advanced
DMEM/F-12 (GIBCO ref. 12634010) and Neurobasal (GIBCO ref. 21103049) supplemented with 1x L-Glutamine (GIBCO ref.
25030024), 1x MEM non-essential amino acids (GIBCO ref.11140035), 0.5x N-2 supplement (GIBCO ref. 17502048), 0.5x
B-27 Supplement (GIBCO ref. 17504044) and 0.1mM 2-mercaptoethanol (GIBCO ref. 31350010). The appropriate number of
cells (100,000 cells per well of a 6-well plate) was transferred into gelatin-coated plates containing N2B27 medium. The medium
was changed every 2 days until analysis.
To assess self-renewal efficiency, ESCs were plated at clonal density (600 cells per well of a 6-well plate) in matrigel-coated (Corn-
ing ref. 354277) plates with N2B27 medium (see composition above) supplemented with ‘‘2i’’ inhibitors (Ying et al., 2008) (1mM
PD0325901 (Axon ref. 1408) and 3mM CHIR99021 (Axon ref. 1386)) and 100U/ml LIF. Following 7 days of culture, cells were fixed
and stained for alkaline phosphatase activity (AP) following manufacturer’s instructions (Sigma-Aldrich ref. 86R-1KT). AP-positive
colonies were imaged using a brightfield microscope (Nikon Ti2) and automatically counted using the ImageJ software.
Genetic manipulation of ESCs
To mutate endogenous Sall4 genomic loci (ZFC4mut, ZFC4D and ZFC1-2D), E14Ju09 ESCs were modified by CRISPR/Cas9 (Ran
et al., 2013). Guide RNAs were designed close to the desired mutation site (https://zlab.bio/guide-design-resources) and cloned into
Cas9/gRNA co-expression plasmids (Addgene pX330, or derivative containing EGFP or a puromycin resistance cassette). Single-
stranded repair DNA templates (ssDNAs) were ordered from Integrated DNA Technologies. ESCs (4x105 cells) were transfected
with one (for point mutations) or two (for deletions) Cas9/gRNA plasmids and 10nmol of ssDNA template as appropriate. If a puro-
mycin resistance cassette was used, cells were selected with puromycin and seeded at clonal density. If a fluorescent reporter was
used, single cells were FACS-sorted and plated into wells of 96-well plates. ESC clones were expanded and their genomic DNA was
extracted for genotyping by PCR (see primers) and Sanger sequencing.
To generate cell lines expressing a transgene of interest (Sall4 or EGFP cDNA) under a doxycycline-inducible promoter, Sall4
knockout ESCs were modified using the PiggyBac (PB) transposon system. 1x106 Sall4 knockout ESCs were transfected with
two PiggyBac vectors (‘‘PB-(TetO)8-Sall4-PGK-Hygromycin
R’’ or ‘‘PB-(TetO)8-EGFP-PGK-Hygromycin
R’’ + ‘‘PB-Tet-On 3G-IRES-
ZeocinR’’), together with a third plasmid expressing hyperactive PB transposase (Yusa et al., 2011) (pCMV-hyPBase). Approximately
48h post-transfection, ESCswere selected for 12 dayswith 200mg/ml hygromycin (doxycycline-inducible SALL4 or EGFP constructs)
and 100mg/ml zeocin (Tet-On 3G transactivator construct). This experiment was repeated three times to obtain independent repli-
cates for each cell line (SALL4 or EGFP). During selection, no doxycycline was added to the medium in order to prevent SALL4 or
EGFP expression. To induce SALL4 or EGFP expression, cells were treated for 48h with 1mg/ml doxycycline (freshly prepared).
For each replicate, SALL4 expression with and without doxycycline was controlled by RT-qPCR and immunofluorescence, as
described below.
METHOD DETAILS
DNA pulldown and mass spectrometry
SILAC culture, preparation of heavy/light labeled nuclear protein extracts, DNA pulldowns and mass spectrometry were performed
according to a previously published protocol (Spruijt et al., 2013b), with minor changes. Biotinylated bait (AT-run) and control (dis-
rupted AT-run) DNA oligonucleotides (see Table S4) were purchased from Sigma-Aldrich and annealed as described. Poly(dI-dC)
(Sigma-Aldrich ref. P4929) was used as competitor. Heavy- and light-labeled mouse ESC protein extracts were incubated with im-
mobilized biotinylated DNA probes. After incubation andwashes, beads from both pulldownswere combined after which bound pro-
teins were digested with trypsin. Finally, the heavy/light ratio for the tryptic peptides was measured by LC-MS. Two replicate DNA
pulldown/mass spectrometry experiments were performed with both bait/control pairs. The first experiment was done according to
protocol using magnetic Dynabeads MyOne Streptavidin C1 (Thermo Fisher Scientific ref. 65001) and in-gel digestion of samples
after elution. In the second replicate experiment, agarose streptavidin beads (Thermo Fisher Scientific) were used and samples
were digested on-beads prior to elution. Peptides were concentrated and desalted using StageTips (Rappsilber et al., 2003), before
being analyzed on an EASY-nLC (Thermo Fisher Scientific) connected online to an LTQ-Orbitrap Velos mass spectrometer (Thermo
Fisher Scientific). Peptides were measured during a 120min acetonitrile gradient using CID fragmentation of the top 15 precursor
ions, with a dynamic exclusion duration of 30sec. Raw data was analyzed using MaxQuant (Cox and Mann, 2008) version 1.3.0.5.
Using Perseus (Tyanova et al., 2016), the data was filtered for contaminants, reverse hits and the number of (unique) peptides. A scat-
terplot of the filtered data was generated using R. Detailed results from mass spectrometry analyses are available in Table S1.
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DNA pulldowns for subsequent western blot analysis (see below) required scaling down of oligonucleotides, beads, Poly(dI-dC)
competitor and total buffer volumes for use with 100mg or 200mg of nuclear protein extract. After binding of DNA oligonucleotides
and washes with DNA binding buffer, beads were washed twice with protein binding buffer containing 0.5% BSA and blocked for
15min at room temperature. After incubation with nuclear protein extract, beads were washed five times in protein binding buffer
and bound proteins were eluted by incubating beads in 50ml of NuPAGE LDS Sample Buffer (Thermo Fisher Scientific) for 15min
at 70C.
Immunoprecipitation
To prepare protein extracts for immunoprecipitation, ESCs were washed with PBS, trypsinised and collected in 15ml tubes.
Following a centrifugation for 5min at 1,300rpm, the supernatant was removed and the cell pellet was resuspended in 1ml of lysis
buffer (10mM NaCl, 1mM MgCl2, 20mM HEPES pH7.5, 0.1% (v/v) Triton X-100) freshly supplemented with 1x protease inhibitor
cocktail (Roche ref. 11873580001) and 0.5mM DTT. After a 20min incubation on ice with occasional shaking, nuclei were pelleted
by centrifugation at 4C for 10min at 1,500rpm. Supernatant was removed and nuclei were resuspended in 1ml of lysis buffer freshly
supplemented with 1x protease inhibitor cocktail and 0.5mMDTT. The material was transferred into 1.5ml LoBind tubes (Eppendorf)
and supplemented with 250U of Benzonase nuclease (Sigma-Aldrich). After a 5min incubation at room temperature, samples were
supplemented with NaCl to obtain a final concentration of 150mM NaCl. Samples were incubated on a rotating wheel for 30min at
4C. Tubes were centrifuged at 4C for 30min at 13,300rpm and supernatants (nuclear protein extracts) were transferred into new
1.5ml LoBind tubes. 50ml of nuclear protein extract was boiled for 5min at 90C in 2x Laemmli buffer (Sigma-Aldrich ref. S3401)
as input material. Nuclear extracts were used directly for immunoprecipitation or stored at 80C.
For immunoprecipitations, 5mg of anti-SALL4 antibody (Abcam ref. ab29112, RRID:AB_777810) was added to each nuclear protein
extract (Sall4 knockout protein extracts were used as negative control). Sampleswere incubated overnight at 4Con a rotating wheel.
30ml of nProteinA Sepharose beads (GE Healthcare 4 Fast Flow), previously blockedwith 0.5mg/ml BSA, were added to each nuclear
extract and samples were incubated for 2h at 4C on a rotating wheel. Samples were washed 5 times in lysis buffer freshly supple-
mented with 0.5mM DTT. Between each wash, samples were centrifuged at 4C for 1min at 2,000rpm. After the final wash, beads
were boiled for 5min at 90C in 2x Laemmli buffer (Sigma-Aldrich ref. S3401) to elute the immunoprecipitated material.
Western blot
For western blot analysis, samples were loaded into 4%–15% Mini-PROTEAN TGX Precast gels (Bio-Rad), together with a fluores-
cent protein ladder (LI-COR ref. 928-60000). Proteins were separated by electrophoresis in SDS running buffer for 45min at 200V.
Subsequently, proteins were transferred on a nitrocellulose membrane at 4C overnight at 23V. Themembrane was blocked for 1h at
room temperature with PBS supplemented with 10% non-fat skimmedmilk and 0.1% Tween. Themembrane was then incubated for
90min at room temperaturewith primary antibodies (see Table S4) diluted at the appropriate concentration in PBS supplementedwith
5% non-fat skimmed milk and 0.1% Tween. The membrane was washed 4 times with PBS supplemented with 0.1% Tween, and
incubated for 2h at room temperature with fluorescently labeled (LI-COR IRDye) or HRP-conjugated (GE Healthcare) secondary an-
tibodies diluted in PBS supplemented with 5% non-fat skimmed milk and 0.1% Tween. The membrane was finally washed 4 times
with PBS supplemented with 0.1%Tween. Proteins were visualized using the LI-COROdyssey CLx imaging system (fluorescence) or
detected on film by chemiluminescence (PerkinElmer ECL kit). Western blot signal was quantified using the LI-COR Image Studio
software by measuring the fluorescence intensity of appropriate protein bands.
Immunofluorescence
For high resolution imaging, cells were plated on chambered coverslips (Ibidi ref. 80286). For lower magnification, cells were grown
on standard tissue culture dishes. Cells were washed with PBS and fixed with 4% PFA for 10min at room temperature. After fixation,
cells were washed with PBS and permeabilised for 10min at room temperature in PBS supplemented with 0.3% (v/v) Triton X-100.
Sampleswere blocked for 1h30min at room temperature in blocking buffer: PBS supplementedwith 0.1% (v/v) Triton X-100, 1% (w/v)
BSA and 3% (v/v) serum of the same species as secondary antibodies were raised in (ordered from Sigma-Aldrich). Following block-
ing, samples were incubated overnight at 4C with primary antibodies (see Table S4) diluted at the appropriate concentration in
blocking buffer. After 4 washes in PBS supplemented with 0.1% (v/v) Triton X-100, samples were incubated for 2h at room temper-
ature (in the dark) with fluorescently labeled secondary antibodies (Invitrogen Alexa Fluor Plus antibodies) diluted 1:1,000 in blocking
buffer. Cells were washed 4 times with PBS supplemented with 0.1% (v/v) Triton X-100. DNAwas stained with 4’,6-diamidino-2-phe-
nylindole (DAPI) for 5min at room temperature, and cells were submitted to a final wash with PBS. Samples were imaged by fluores-
cence microscopy (Nikon Ti2 or Zeiss LSM 880 with Airyscan). Images were analyzed and processed using the software Fiji.
RT-qPCR
Cells were directly lysed on the plate and total RNA was isolated using the RNeasy Plus Mini kit (QIAGEN ref. 74136), following man-
ufacturer’s instructions. The quantity and purity of RNA samples were determined using a micro-volume spectrophotometer
(Nanodrop ND-1000). RNA was reverse-transcribed with SuperScript IV and random hexamers (Invitrogen ref. 18091050), following
manufacturer’s instructions. Triplicate qPCR reactions were set up in 384-well plates using the Takyon SYBRMastermix (Eurogentec
ref. UF-NSMT-B0701) and appropriate primer pairs (see Table S4). qPCR was performed and analyzed using the Roche LightCycler
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480 machine. For each primer pair, a standard curve was performed to assess amplification efficiency and melting curves were
analyzed to verify the production of single DNA species.
HT-Selex
SELEX coupled with high-throughput sequencing (HT-SELEX) was performed as previously described (Jolma et al., 2010; Nitta et al.,
2015), in three independent replicate experiments. All oligonucleotides were ordered from Integrated DNA Technologies (see Table
S4). SELEX libraries were generated by PCR and consisted of 20bp random sequences flanked by primer binding sites for amplifi-
cation. Double-stranded DNA libraries were purified using the MinElute PCR Purification Kit (QIAGEN ref. 28004) and controlled on a
10% polyacrylamide gel.
For SELEX experiments, recombinant SALL4 ZFC1 (residues 320-486), ZFC2 (residues 551-662) or ZFC4 (residues 859-1028) with
an N-terminal hexahistidine tag were expressed from a pET-based vector in E.coli BL21 (DE3) cells. Proteins were purified using a
5mL Histrap FF column, followed by separation by ion exchange (6 mL ResS column) and size exclusion chromatography (Superdex
200 16/600, all columns fromGEHealthcare). SELEX libraries (1.5mg for the first cycle, 200ng for subsequent cycles) weremixed with
1mg of hexahistidine-tagged SALL4 ZFC in 100ml of SELEX buffer (50mMNaCl, 1mMMgCl2, 0.5mMEDTA, 10mMTris-HCl pH7.5, 4%
glycerol) freshly supplemented with 5mg/ml Poly(dI-dC) and 0.5mMDTT. A negative control experiment (without addition of proteins)
was also performed to control for technical bias during the SELEX protocol. Following a 10min incubation at room temperature on a
rotating wheel, 50ml of Ni Sepharose 6 Fast Flow beads (GE Healthcare), previously equilibrated in SELEX buffer, were added to each
sample and incubated for an additional 20min at room temperature on a rotating wheel. To remove non-specifically bound oligonu-
cleotides, beads were washed 5 times with 1ml of SELEX buffer, freshly supplemented with 0.5mM DTT. Between each wash, sam-
ples were incubated for 5min at room temperature on a rotating wheel and centrifuged for 1min at 2,000 rpm. After the final wash,
beads were resuspended in 100ml H2O and used directly for PCR using the high-fidelity Phusion DNA polymerase (NEB ref. M0530S).
The minimum number of PCR cycles required to amplify each library was determined by running samples amplified with increasing
PCR cycle numbers on 10% polyacrylamide gels. Amplified libraries were purified using the MinElute PCR Purification Kit and used
for subsequent rounds of SELEX. To generate libraries for high-throughput sequencing at the desired number of SELEX cycles,
libraries were amplified using primers containing Illumina adapters and unique barcodes. Double-stranded DNA libraries were puri-
fied using the QIAquick PCR Purification Kit (QIAGEN ref. 28104). Contaminating primers were eliminated by size exclusion using
KAPA Pure beads (Roche ref. 07983271001) with a 3x beads-to-sample ratio. SELEX libraries with unique barcodes were pooled
in equimolar amounts and sequenced using the Illumina MiSeq platform (EMBL GeneCore facility, Germany).
ChIP-seq
ChIP was performed as previously described (Stock et al., 2007), in two or three independent replicate experiments for each sample.
For each ChIP, 25x106 ESCs were plated into 15cm dishes the day before the experiment. Cells were crosslinked at 37C for 10min
with 1% formaldehyde. Following quenching for 5min at room temperature with 125mM glycine, cells were washed 3 times with ice-
cold PBS. Swelling buffer (10ml of 10mM KCl, 1.5mMMgCl2, 25mM HEPES pH7.9, 0.1% NP-40) freshly supplemented with 1x pro-
tease inhibitor cocktail (Roche ref. 11873580001) was added into each plate, followed by a 10min incubation at 4C. Nuclei were
collected by scraping and transferred into 15ml tubes. Samples were centrifuged at 4C for 5min at 3,000rpm and the supernatant
was removed. Crosslinked nuclei were quickly frozen on dry ice and stored at80C. Crosslinked nuclei were thawed on ice, resus-
pended in 2ml of sonication buffer (140mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1% SDS, 50mM HEPES
pH7.9) freshly supplemented with 1x protease inhibitor cocktail, and transferred into 1.5ml TPX tubes (Diagenode). Chromatin was
sonicated by performing 20x sonication cycles (30sec on/ 30sec off) using the Bioruptor Twin instrument (Diagenode) with a 4Cwa-
ter bath. Samples were centrifuged at 4C for 30min at 13,000rpm to remove insoluble material. Supernatants (soluble chromatin
fraction) were collected and transferred into 1.5ml LoBind tubes (Eppendorf). To evaluate the amount of chromatin in each sample,
a 2ml aliquot was alkaline-lysed with 0.1M NaOH and measured using a micro-volume spectrophotometer (Nanodrop ND-1000).
For each immunoprecipitation, 700mg of chromatin was mixed with 5mg of anti-SALL4 antibody (Santa Cruz ref. sc-101147, RRI-
D:AB_1129262 or Abcam ref. ab29112, RRID:AB_777810) in a total volume of 1ml of sonication buffer supplemented with 1x prote-
ase inhibitor cocktail.Sall4 knockout ESCs chromatin samples were used as a negative control. Samples were incubated overnight at
4C on a rotating wheel. 50ml of either Protein A (ChIP with Abcam ref. ab29112) or Protein G (ChIP with Santa Cruz ref. sc-101147)
magnetic beads (Invitrogen Dynabeads), previously equilibrated in sonication buffer, was added into each sample. Following a 3h
incubation at 4C on a rotating wheel, beads were extensively washed with 1ml of each of the following buffer: 1x with sonication
buffer, 1x with wash buffer A (500mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1% SDS, 50mM HEPES
pH7.9), 1x with wash buffer B (250mM LiCl, 1mM EDTA, 0.5% NP-40, 0.5% Na-deoxycholate, 20mM Tris pH8.0), 2x with TE buffer
(Sigma-Aldrich ref. 93283). Between each wash, beads were incubated for 5min at room temperature on a rotating wheel. Finally,
DNA was eluted by resuspending beads in 250ml of elution buffer (50mM Tris pH7.5, 1mM EDTA) freshly supplemented with 1%
SDS, and by incubating samples at 65C for 5 min. Samples were further incubated for 15min at room temperature on a rotating
wheel and the supernatant (eluted chromatin) was collected into a new 1.5ml LoBind tube. The elution was repeated a second
time to obtain 500ml of immunoprecipitated chromatin.
To extract DNA from immunoprecipitated chromatin or from the input material (50ml of soluble chromatin), crosslinking was
reversed by incubating samples overnight at 65C in a total volume of 500ml with 160mM NaCl and 20 mg/ml RNase A. Then,
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5mM EDTA and 200 mg/ml Proteinase K were added to the samples, followed by a 2h incubation at 45C. Finally, DNA was pu-
rified by phenol-chloroform extraction (Invitrogen ref. 15593031) followed by ethanol precipitation with 2x volumes of 100%
ethanol, 0.1x volume of 3M sodium acetate, and 40mg of glycogen (Invitrogen ref. 10814010). Samples were incubated at
80C for at least 1h and centrifuged at 4C for 30min at 13,000rpm. The supernatant was removed and DNA pellets were
washed with 70% EtOH. Following a final spin at 4C for 15min at 13,000rpm, DNA pellets were air-dried and resuspended in
30-100ml TE buffer (Sigma-Aldrich ref. 93283) or H2O. DNA concentration was quantified using the Qubit dsDNA HS Assay Kit
(Invitrogen ref. Q32854).
ChIP-seq libraries were prepared using the KAPA Hyperprep Kit (Roche ref. 07962347001) together with KAPA dual-indexed
adapters (Roche ref. 08278555702), following manufacturer’s instruction. ChIP-seq libraries were quantified using the Qubit dsDNA
HS Assay Kit (Invitrogen ref. Q32854) and fragment size was evaluated using the Agilent 2100 Bioanalyzer (Agilent High Sensitivity
DNA Kit). ChIP-seq libraries with unique barcodes were pooled in equimolar amounts and sequenced using the Illumina HiSeq 4000
and NextSeq 500 platforms (EMBL GeneCore facility, Germany).
ATAC-seq
ATAC-seq was performed as previously described (Cholewa-Waclaw et al., 2019). ESC nuclei from three independentWT ESC rep-
licates were isolated using hypotonic buffer (10mM Tris-HCl pH7.4, 10mM NaCl, 3mM MgCl2, 0.1% Igepal CA-630). 50,000 nuclei
were resuspended in 50ml of transposition reaction mix containing 2.5 mL Nextera Tn5 Transposase and 2x TD Nextera reaction
buffer. The mix was incubated for 30 min at 37C. DNA was purified and PCR amplified with the NEBNext High Fidelity reaction
mix (NEB) to generate DNA libraries. Libraries were sequenced using the Illumina HiSeq 2500 platform with 75bp paired-end
sequencing.
RNA-seq
For RNA-seq in ESCs, all cell lines were seeded at the same density in 6-well plates, in three or four independent replicate experi-
ments for each sample. Following two days of culture, total RNA was extracted using the AllPrep DNA/RNA kit (QIAGEN) or the
RNeasy Plus Mini kit (QIAGEN), following the manufacturer’s instructions and contaminating genomic DNA was removed by DNase
I treatment. Before library preparation, equal amounts of either RNA sequins (Garvan Institute of Medical Research, Australia) or
ERCC (Invitrogen) spike-in mix were added to each sample. Ribosomal RNA-depleted RNA-seq libraries were prepared using either
the ScriptSeq Complete Gold Kit (Illumina) or the KAPA RNA Hyperprep Kit (Roche ref. 08098131702) together with indexed
adapters, following the manufacturer’s instructions. RNA-seq libraries with unique barcodes were pooled in equimolar amounts
and sequenced using the Illumina HiSeq 2500 (Wellcome Sanger Institute, UK), HiSeq X (Novogene Europe, UK) or NextSeq 500
(EMBL GeneCore facility, Germany) platforms.
For the RNA-seq time course experiment, cells were submitted to neuronal differentiation as previously described (see cell culture
section), in two independent replicate experiments for each sample. At the appropriate time point, cells were directly lysed on the
plate and total RNA was extracted using the RNeasy Plus Mini kit (QIAGEN), following the manufacturer’s instructions and contam-
inating genomic DNA was removed by DNase I treatment. Equal amounts of RNA sequins spike-in mix (Garvan Institute of Medical
Research, Australia) were added to each sample and RNA-seq libraries were prepared by polyA-enrichment using the NEBNext Ultra
II Library Prep Kit (NEB ref. E7645) together with indexed adapters. RNA-seq libraries with unique barcodes were pooled in equimolar
amounts and sequenced using the Illumina NovaSeq platform (Novogene Europe, UK).
QUANTIFICATION AND STATISTICAL ANALYSIS
HT-SELEX analysis
All possible k-mers (width = 5) were searched individually in all SELEX libraries at different cycles. The fraction of reads containing the
k-mer was considered as its abundance. Subsequently, top 3 abundant k-mers from ZFC4 SELEX library at cycle 6 were searched
allowing one mismatch and a position frequency matrix (PFM) was generated for each. The PFM was used to visualize the motifs
using Logolas (Dey et al., 2018).
RNA-seq analysis
Alignment-free quantification from RNA-seq data was performed using sailfish v0.9.2 (Patro et al., 2014). Annotation data was down-
loaded fromGencode and a transcriptome index was generated for assembly releaseM23. Differential gene expression analysis was
performed using DESeq2 v1.28.0 (Love et al., 2014) and genes with adjusted p value < 0.05 were considered for further analyses.
Genome wide base composition was calculated for 1 kilobase (kb) windows of the mouse genome using bedtools nuc (Quinlan
and Hall, 2010) and the AT content BigWig track was generated. Base composition for multiple gene loci was calculated using deep-
Tools computeMatrix (Ramı́rez et al., 2014). Gene ontology analysis for genes deregulated in ZFC4mut/D ESCswas performed using
clusterProfiler Bioconductor package (Yu et al., 2012) and simplified GO terms from enrichGO function were used to identify enriched
GO Terms with q-value < 0.01 as significance threshold (see Table S3). Bootstrapped two-sided t tests were used to associate sta-
tistical significance for comparisons of log2 fold changes in different Sall4 mutants compared to wild-type (WT) for neuronal differ-
entiation genes. Command line arguments and source code for analysis is detailed in Methods S1.
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ChIP-seq analysis
Sequencing reads were trimmed using Trimmomatic v0.33 (Bolger et al., 2014) and aligned to mm10 assembly using bwa-mem
v0.7.17 (Li, 2013). PCR duplicate sequencing reads were removed using MarkDuplicates from Picard toolkit (http://broadinstitute.
github.io/picard/). GC-bias was estimated for input chromatin samples using computeGCBias (Benjamini and Speed, 2012) from
deepTools (Ramı́rez et al., 2014). Subsequently, both ChIP and input chromatin samples were corrected using the input chromatin
estimated bias using correctGCBias. Peak calling on the GC-bias corrected BAM files was performed using MACS v2.1.2 (Zhang
et al., 2008). BigWig tracks for ChIP over input chromatin were calculated using bamCompare. For meta-analyses of peak regions,
ChIP signal scores per genome regions was calculated using computeMatrix. Motif discovery and motif enrichment analysis was
performed using MEME-ChIP v5.1.0 (Machanick and Bailey, 2011) for ChIP-seq peaks with background sequences randomly
sampled from accessible chromatin regions. Command line arguments and source code for analysis is detailed in Methods S1.
ATAC-seq analysis
Sequencing reads were trimmed using Trimmomatic v0.33 (Bolger et al., 2014) and aligned to mm10 assembly using bwa-mem
v0.7.17 (Li, 2013). PCR duplicate sequencing reads were removed using MarkDuplicates from Picard toolkit (http://broadinstitute.
github.io/picard/). Broad peak calling on the de-duplicated BAM files was performed using MACS v2.1.2 (Zhang et al., 2008).
Quantification of AT effect
Ordinary least-squares (OLS) linear regression was fitted by selecting RNA-seq log2 fold change as an endogenous variable and
average AT content across the gene locus as an exogenous variable. For every model fit, the p value associated with the F-statistic
and quantified AT effect with a confidence interval of 99% was used for further analysis. R2 values were estimated from a linear
regression fit when log2 fold change is regressed against AT content across gene locus. p values obtained from all model fits
were adjusted using the Benjamini/Hochberg multiple testing comparison and models with a false discovery rate (FDR) < 0.01
were deemed significant. Detailed results from statistical analyses are available in Table S2. Command line arguments and source
code for analysis is detailed in Methods S1.
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